IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
about
Dysregulation of suppressor of cytokine signaling 3 in keratinocytes causes skin inflammation mediated by interleukin-20 receptor-related cytokinesDetection of interleukin-19 mRNA in C57BL/6 mice astroglial cells and brain cortex.Cytokine-modulating strategies and newer cytokine targets for arthritis therapy.Cytokine detection and simultaneous assessment of rheumatoid factor interference in human serum and synovial fluid using high-sensitivity protein arrays on plasmonic gold chips.Interleukin-19 in fetal systemic inflammation.Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines.Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic miceExpression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment.The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression.Intracellular Signaling Pathways in Rheumatoid ArthritisChemokine receptors in psoriasis.Treating moderate to severe psoriasis - best use of biologics.Therapeutic targets for rheumatoid arthritis: Progress and promises.The therapeutic potential of anti-interleukin-20 monoclonal antibody.Immunoregulatory Pathways Involved in Inflammatory Bowel Disease.Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.The IL-20 receptor axis in immune-mediated inflammatory arthritis: novel links between innate immune recognition and bone homeostasis.A review on interleukins: The key manipulators in rheumatoid arthritis.Biomarkers in inflammatory bowel diseases: insight into diagnosis, prognosis and treatment.Increased interleukin (IL)-20 and IL-24 target osteoblasts and synovial monocytes in spondyloarthritis.Modulation of Th1/Tc1 and Th17/Tc17 responses in pulmonary tuberculosis by IL-20 subfamily of cytokines.IL-20 bone diseases involvement and therapeutic target potential.The IL-20 Cytokine Family in Rheumatoid Arthritis and SpondyloarthritisExpression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study
P2860
Q28727511-70C982B5-7083-4570-8D81-4B3FBEF500BFQ34368204-FF39C5A7-7F99-493D-B4A2-819DC6B10D37Q34456715-05FEF0D2-9A7D-454B-A424-05C97D9A0483Q35744354-868238E3-ED96-4613-B168-B5B79CD2DD3AQ36060670-DE7DBEAA-0F56-4BB4-9FAC-5A61C1572AA9Q36338729-F4ACFB36-C93E-444B-A132-A02A3B258B79Q36545638-8FA1C991-CF68-40FA-B566-88541DA11655Q36633128-A01432F8-896A-46AD-852D-3CBB236E0BC8Q36679272-7310D757-B44F-4FD0-ACB1-FD1E84AF5EBAQ37626617-BCFEDEA2-C5C8-47CB-9D60-EE1C6C68D715Q38144211-1FFC23DC-84BC-4EB2-A5E1-37C04EBDB29BQ38174153-DAFECF5F-B271-4E29-A7C8-B6F6859B9DF4Q38179461-49CECB10-B0B8-46DF-8E50-936CD664D4AFQ38210876-29047361-A547-4ACC-B97C-64AE8ED3FE7AQ38537820-8568AC19-C614-4ED0-AE23-5D16BA75978FQ38966071-2663CB6C-BDA8-424B-8A42-BA4752CE3068Q38968418-3D43071B-01E5-47BB-9F01-A7C366E22F80Q39029629-8CC58921-041D-4974-8356-BABE1C97456CQ45898977-6EFC4DB0-3127-40EC-A31C-199CA0E8E394Q46275316-62EBFE5D-AAE5-4DC3-A98E-AC0D0C2E11DEQ52569523-689C394D-3699-4411-AE8C-6E0230F1CADCQ55121772-C852E8BF-5A0A-4A39-8C1B-ECDAF64BE303Q57492001-48F453F2-E1C5-49D3-9FD1-E625032BAD68Q57735526-40A528E9-8530-4155-8A08-AC35F2BD233D
P2860
IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
@en
IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
@nl
type
label
IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
@en
IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
@nl
prefLabel
IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
@en
IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
@nl
P2093
P2860
P1476
IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
@en
P2093
Dong-Qing Ye
Jin-Hui Tao
Rui-Xue Leng
P2860
P304
P356
10.1517/14728222.2011.534461
P407
P50
P577
2010-11-12T00:00:00Z